January 29, 2014 Quest PharmaTech Inc. , a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that is has entered into a license agreement with U.S. based Oncovir, Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Oncovir's immune activator ... (more)
http://ift.tt/1nlXtvL
http://ift.tt/1nlXtvL
No comments:
Post a Comment